187 related articles for article (PubMed ID: 36200184)
1. Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation.
Petrucci G; Giaretta A; Ranalli P; Cavalca V; Dragani A; Porro B; Hatem D; Habib A; Tremoli E; Patrono C; Rocca B
Clin Transl Sci; 2022 Dec; 15(12):2958-2970. PubMed ID: 36200184
[TBL] [Abstract][Full Text] [Related]
2. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
Landolfi R; Ciabattoni G; Patrignani P; Castellana MA; Pogliani E; Bizzi B; Patrono C
Blood; 1992 Oct; 80(8):1965-71. PubMed ID: 1327286
[TBL] [Abstract][Full Text] [Related]
3. Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives.
Landolfi R; Patrono C
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():83-6. PubMed ID: 8951777
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Reilly IA; FitzGerald GA
Blood; 1987 Jan; 69(1):180-6. PubMed ID: 3790723
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients.
Santilli F; Romano M; Recchiuti A; Dragani A; Falco A; Lessiani G; Fioritoni F; Lattanzio S; Mattoscio D; De Cristofaro R; Rocca B; Davì G
Blood; 2008 Aug; 112(4):1085-90. PubMed ID: 18541722
[TBL] [Abstract][Full Text] [Related]
6. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
7. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
8. Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
Tosetto A; Rocca B; Petrucci G; Betti S; Soldati D; Rossi E; Timillero A; Cavalca V; Porro B; Iurlo A; Cattaneo D; Bucelli C; Dragani A; Di Ianni M; Ranalli P; Palandri F; Vianelli N; Beggiato E; Lanzarone G; Ruggeri M; Carli G; Elli EM; Priolo S; Randi ML; Bertozzi I; Loscocco GG; Ricco A; Specchia G; Vannucchi AM; Rodeghiero F; De Stefano V; Patrono C;
Clin Pharmacol Ther; 2022 Apr; 111(4):939-949. PubMed ID: 34743317
[TBL] [Abstract][Full Text] [Related]
9. Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation.
Petrucci G; Zaccardi F; Giaretta A; Cavalca V; Capristo E; Cardillo C; Pitocco D; Porro B; Schinzari F; Toffolo G; Tremoli E; Rocca B
J Thromb Haemost; 2019 Jun; 17(6):885-895. PubMed ID: 30933424
[TBL] [Abstract][Full Text] [Related]
10. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
12. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
Gurbel PA; Bliden KP; Tantry US
J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
14. Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin.
Finneran MM; Gonzalez-Brown VM; Smith DD; Landon MB; Rood KM
Am J Obstet Gynecol; 2019 Apr; 220(4):385.e1-385.e6. PubMed ID: 30786253
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
16. Aspirin dosage and thromboxane synthesis in patients with vascular disease.
Hart RG; Leonard AD; Talbert RL; Pearce LA; Cornell E; Bovill E; Feinberg WM
Pharmacotherapy; 2003 May; 23(5):579-84. PubMed ID: 12741431
[TBL] [Abstract][Full Text] [Related]
17. Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A
D'Agostino I; Tacconelli S; Bruno A; Contursi A; Mucci L; Hu X; Xie Y; Chakraborty R; Jain K; Sacco A; Zucchelli M; Landolfi R; Dovizio M; Falcone L; Ballerini P; Hwa J; Patrignani P
Pharmacol Res; 2021 Aug; 170():105744. PubMed ID: 34182131
[TBL] [Abstract][Full Text] [Related]
18. The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B
De Stefano V; Rocca B; Tosetto A; Soldati D; Petrucci G; Beggiato E; Bertozzi I; Betti S; Carli G; Carpenedo M; Cattaneo D; Cavalca V; Dragani A; Elli E; Finazzi G; Iurlo A; Lanzarone G; Lissandrini L; Palandri F; Paoli C; Rambaldi A; Ranalli P; Randi ML; Ricco A; Rossi E; Ruggeri M; Specchia G; Timillero A; Turnu L; Vianelli N; Vannucchi AM; Rodeghiero F; Patrono C
Blood Cancer J; 2018 Jun; 8(6):49. PubMed ID: 29880847
[TBL] [Abstract][Full Text] [Related]
19. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
Bode-Böger SM; Böger RH; Schubert M; Frölich JC
Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
[TBL] [Abstract][Full Text] [Related]
20. On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens.
Cavalca V; Rocca B; Veglia F; Petrucci G; Porro B; Myasoedova V; De Cristofaro R; Turnu L; Bonomi A; Songia P; Cavallotti L; Zanobini M; Camera M; Alamanni F; Parolari A; Patrono C; Tremoli E
Clin Pharmacol Ther; 2017 Nov; 102(5):849-858. PubMed ID: 28379623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
